Fmoc-Cys(pMeOBzl)-OH is a protected cysteine derivative used as a building block in solid-phase peptide synthesis. The Fmoc group protects the amino terminus, while the p-methoxybenzyl (pMeOBzl) group serves as a thiol-protecting moiety, enabling selective deprotection during peptide assembly.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 141892-41-3
Fmoc-O-tert-butyl-D-serine
pharmaceutical intermediate
Fmoc-(2S,3R)-AHPA
pharmaceutical intermediate
L-Glutamic acid 1-tert-Butyl ester hydrochloride
pharmaceutical intermediate
N-Fmoc-S-trityl-L-homocysteine
pharmaceutical intermediate
Benzoic acid, 2,5-diiodo-
pharmaceutical intermediate
Methyl 2-oxoindole-6-carboxylate
pharmaceutical intermediate
Ethyl (3R)-4-cyano-3-hydroxybutanoate
pharmaceutical intermediate
N,N,N'-Trimethylethylenediamine
pharmaceutical intermediate
(2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-[(4-methoxyphenyl)methylsulfanyl]propanoic acid
IWZGYHFOLFRYPK-DEOSSOPVSA-N
COC1=CC=C(C=C1)CSC[C@@H](C(=O)O)NC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24